MYCN and neuroblastoma: Alterations in copy number or changes in expression of MYCN has also been reported in other cancers such as neuroblastoma [22], medulloblastoma [23], glioblastoma multiforme [24,25], Rhabdomyosarcoma [26] and pancreatic tumors [27].